| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 164.204 | 81 |
| GSM780708 | Untreated after 4 days (C2_1) | 150.715 | 80 |
| GSM780709 | Untreated after 4 days (C3_1) | 113.833 | 77 |
| GSM780719 | Untreated after 4 days (C1_2) | 139.555 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 147.696 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 130.109 | 79 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 131.924 | 79 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 148.559 | 80 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 129.126 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 133.499 | 79 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 148.207 | 80 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 133.976 | 79 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 140.093 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 139.108 | 80 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 139.671 | 80 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 127.976 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 134.397 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 132.792 | 79 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 96.1734 | 75 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 89.7464 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 131.565 | 79 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 100.061 | 75 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 132.026 | 79 |